• Return to Headlines

Shares of Amag Pharmaceuti Fall to a New 52-Week Low

By Nick Russo

Shares of Amag Pharmaceuti (NASDAQ:AMAG) traded at a new 52-week low today of $8.25. Approximately 741,000 shares have changed hands today, as compared to an average 30-day volume of 697,000 shares.

Potential upside of 151.9% exists for Amag Pharmaceuti, based on a current level of $8.25 and analysts' average consensus price target of $20.78. The stock should find initial resistance at its 50-day moving average (MA) of $10.52 and further resistance at its 200-day MA of $15.62.

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Amag Pharmaceuti share prices have moved between a 52-week high of $26.10 and the current low of $8.25 and are currently at $8.25 per share. The 200-day and 50-day moving averages have moved 1.47% lower and 2.22% lower over the past week, respectively.

SmarTrend recommended that its subscribers protect gains by selling shares of Amag Pharmaceuti on November 1st, 2018 by issuing a Downtrend alert when the shares were trading at $17.89. Since that call, shares of Amag Pharmaceuti have fallen 52.3%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows amag pharmaceuti

Ticker(s): AMAG